The Department of Science and Technology (DOST) said the “latest protocol" for the country’s eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients...
The Department of Science and Technology (DOST) said Sunday, Oct. 31, that the eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in...
The Philippines has conducted clinical studies to determine the efficacy of virgin coconut oil (VCO) as adjunct treatment against coronavirus disease (COVID-19). (MANILA BULLETIN FILE PHOTO ) Department of Science and Technology (DOST) Undersecretary for Research and Development (R&D) Dr....
The country’s clinical trials on the use of virgin coconut oil (VCO), lagundi (Chinese chaste tree) and tawa-tawa (Euphorbia hirta) as adjunct therapy, herbal medicine, and adjunctive treatment against coronavirus disease (COVID-19) may benefit the country’s farmers, the Department of Science...
The Department of Science and Technology (DOST) said Saturday, Oct. 23, said the recruitment of over 1,400 participants for the eight month-long clinical Ivermectin clinical trials is expected to start in November, and that the initial results of the study may be out by end of December this year....
Bracing for “good results,” the Department of Science and Technology (DOST) said Thursday, Oct. 21, that the drug developers and the public are expected to benefit from the country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug...
Tawa-tawa (Euphorbia hirta) extract is proving to be an effective adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases, the Department of Science and Technology (DOST) disclosed. Tawa-tawa (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development...
Using lagundi as herbal medicine for mild coronavirus disease (COVID-19) patients yielded positive results, the Department of Science and Technology (DOST) said. Lagundi (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&D) Rowena Cristina Guevara bared the initial...
The country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in isolation facilities will begin on Oct. 15, the Department of Science and Technology...
The clinical trial on the use of anti-parasitic drug Ivermectin for COVID-19 patients in the country has been moved again for one more month, from Sept. 15 to Oct. 15, due to ongoing revisions on its protocols. Department of Science and Technology (DOST) Sec. Fortunato Dela Peña said in a...
The Department of Science and Technology (DOST) has invested P8.4 million to determine the safety and efficacy of virgin coconut oil (VCO) as adjunctive therapy for coronavirus disease (COVID-19) patients, and to evaluate its beneficial effects for probable COVID-19 patients who are quarantined in...
The country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) is set to begin on Sept. 15, the Department of Science and Technology (DOST) said Friday, Aug. 27. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and...
